Login / Signup

ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination.

Eunjin RyuJuyeong YooMi-Sun KangNa Young HaYewon JangJinwoo KimYeongjae KimByung-Gyu KimShinseog KimKyungjae MyungSukhyun Kang
Published in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Ubiquitination status of proliferating cell nuclear antigen (PCNA) is crucial for regulating DNA lesion bypass. After the resolution of fork stalling, PCNA is subsequently deubiquitinated, but the underlying mechanism remains undefined. We found that the N-terminal domain of ATAD5 (ATAD5-N), the largest subunit of the PCNA-unloading complex, functions as a scaffold for Ub-PCNA deubiquitination. ATAD5 recognizes DNA-loaded Ub-PCNA through distinct DNA-binding and PCNA-binding motifs. Furthermore, ATAD5 forms a heterotrimeric complex with UAF1-USP1 deubiquitinase, facilitating the deubiquitination of DNA-loaded Ub-PCNA. ATAD5 also enhances the Ub-PCNA deubiquitination by USP7 and USP11 through specific interactions. ATAD5 promotes the distinct deubiquitination process of UAF1-USP1, USP7, and USP11 for poly-Ub-PCNA. Additionally, ATAD5 mutants deficient in UAF1-binding had increased sensitivity to DNA-damaging agents. Our results ultimately reveal that ATAD5 and USPs cooperate to efficiently deubiquitinate Ub-PCNA prior to its release from the DNA in order to safely deactivate the DNA repair process.
Keyphrases
  • circulating tumor
  • dna binding
  • single molecule
  • dna repair
  • cell free
  • drug delivery
  • transcription factor
  • dna damage
  • nucleic acid
  • stem cells
  • bone marrow
  • high throughput
  • binding protein